Danish pharmaceutical company Novo Nordisk has reduced the price of its weight-loss drug, Wegovy, by up to 33% in India. This price cut follows the rise of Eli Lilly's Mounjaro as the top-selling weight-loss drug in the country. Wegovy's new costs are now significantly lower across various doses.
Novo Nordisk Slashes Wegovy Prices in India